Global Ischemic Stroke Drugs Market Trends
An increase in the incidence of ischemic strokes
The market for ischemic stroke medications is expected to grow due to the increasing frequency of stroke cases. The factors that cause ischemic stroke include an aging population, sedentary lifestyles, diabetes cases, and high blood pressure. As a result, there is a growing need for medication-based treatment options.
For example, the Centers for Disease Control & Prevention (CDC) estimates that approximately 87% of strokes are ischemic strokes, which occur when blood flow to the brain is interrupted. In 2018 and 2019, the United States spent almost $56.5 billion on stroke-related expenses.
LIMITATIONS:
Exorbitant development costs and strict regulations
Strict inspection and regulatory procedures are involved in developing and approving novel drugs, which could impede the market expansion for ischemic stroke medications. As essential players emerge, there is typically more competition. This is a significant difficulty. There are few treatment options for ischemic stroke, and if some medications are shown to be effective, the market may become oversupplied.